|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-6-12
|
|
pubmed:abstractText |
The potential advantages of osmotic-release oral system (OROS) methylphenidate (Concerta) over immediate-release (IR) methylphenidate (Rubifen) in adults with attention-deficit hyperactivity disorder (ADHD), with respect to medication adherence, effectiveness and tolerability, are yet to be determined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1172-7047
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
603-11
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:18547128-Adult,
pubmed-meshheading:18547128-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:18547128-Central Nervous System Stimulants,
pubmed-meshheading:18547128-Chemistry, Pharmaceutical,
pubmed-meshheading:18547128-Drug Administration Schedule,
pubmed-meshheading:18547128-Female,
pubmed-meshheading:18547128-Follow-Up Studies,
pubmed-meshheading:18547128-Humans,
pubmed-meshheading:18547128-Infusion Pumps, Implantable,
pubmed-meshheading:18547128-Male,
pubmed-meshheading:18547128-Methylphenidate,
pubmed-meshheading:18547128-Outpatients,
pubmed-meshheading:18547128-Retrospective Studies,
pubmed-meshheading:18547128-Spain,
pubmed-meshheading:18547128-Time Factors,
pubmed-meshheading:18547128-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder.
|
|
pubmed:affiliation |
Adult ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain. jaramos@vhebron.net
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
